Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
2.785
+0.035 (1.27%)
Jan 2, 2026, 4:00 PM EST - Market closed
Perspective Therapeutics Market Cap
Perspective Therapeutics has a market cap or net worth of $207.03 million as of January 2, 2026. Its market cap has decreased by -11.98% in one year.
Market Cap
207.03M
Enterprise Value
36.21M
1-Year Change
-11.98%
Ranking
Category
Stock Price
$2.79
Market Cap Chart
Since April 19, 2007, Perspective Therapeutics's market cap has increased from $65.60M to $207.03M, an increase of 215.60%. That is a compound annual growth rate of 6.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 204.40M | -5.19% |
| Dec 31, 2024 | 215.60M | 91.13% |
| Dec 29, 2023 | 112.80M | 221.37% |
| Dec 30, 2022 | 35.10M | -36.18% |
| Dec 31, 2021 | 55.00M | 39.95% |
| Dec 31, 2020 | 39.30M | -6.65% |
| Dec 31, 2019 | 42.10M | 108.42% |
| Dec 31, 2018 | 20.20M | -8.18% |
| Dec 29, 2017 | 22.00M | -31.03% |
| Dec 30, 2016 | 31.90M | -38.18% |
| Dec 31, 2015 | 51.60M | -35.58% |
| Dec 31, 2014 | 80.10M | 317.19% |
| Dec 31, 2013 | 19.20M | -28.89% |
| Dec 31, 2012 | 27.00M | 41.36% |
| Dec 30, 2011 | 19.10M | -28.20% |
| Dec 31, 2010 | 26.60M | 30.39% |
| Dec 31, 2009 | 20.40M | 343.48% |
| Dec 31, 2008 | 4.60M | -90.09% |
| Dec 31, 2007 | 46.40M | -29.27% |
| Apr 19, 2007 | 65.60M | - |
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |